iBio (IBIO) Interest Coverage Ratio (2010 - 2026)
iBio's (IBIO) quarterly Interest Coverage Ratio came in at 59.33 in Q1 2026, down 71.45% year-on-year from 207.79 in Q1 2025, and up 11.43% on a QoQ basis from 66.99 in Q4 2025.
iBio (IBIO) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
iBio (IBIO) has 17 years of Interest Coverage Ratio data on file, last reported at 59.33 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 71.45% year-over-year to 59.33 in Q1 2026; TTM through Mar 2026 was 99.52, a 65.67% increase from a year earlier, with the FY2025 full-year figure at 0.29, up 3.24% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 59.33, up from 66.99 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for IBIO reached as high as 192.52 in Q2 2025 and fell as low as 165.31 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 21.98 across 5 years, with a median of 17.82 in 2022.
- Across the five-year window, Interest Coverage Ratio sank 4581.56% in 2022 and jumped 1486.91% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 2.91 in 2022, then plunged by 389.69% to 14.23 in 2023, then slumped by 120.28% to 31.34 in 2024, then sank by 113.74% to 66.99 in 2025, then increased by 11.43% to 59.33 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 59.33 in Q1 2026, 66.99 in Q4 2025, and 165.31 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | -59.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.33 |
| Dec 31, 2025 | -66.99 |
| Sep 30, 2025 | -165.31 |
| Jun 30, 2025 | 192.52 |
| Mar 31, 2025 | -34.60 |
| Dec 31, 2024 | -31.34 |
| Sep 30, 2024 | -72.04 |
| Jun 30, 2024 | 12.13 |
| Mar 31, 2024 | -25.72 |
| Dec 31, 2023 | -14.23 |
| Sep 30, 2023 | -14.25 |
| Jun 30, 2023 | -8.00 |
| Mar 31, 2023 | -1.71 |
| Dec 31, 2022 | -2.91 |
| Sep 30, 2022 | -7.64 |
| Jun 30, 2022 | -56.50 |
| Mar 31, 2022 | -17.82 |
| Dec 31, 2021 | -35.80 |
| Sep 30, 2021 | -0.16 |
| Jun 30, 2021 | -15.47 |